Cartesian Therapeutics Inc. (RNAC) — Tangible Net Worth Ratio
Cartesian Therapeutics Inc. (RNAC) has a Tangible Net Worth Ratio of -19926.6% as of September 2024. This metric is calculated by deducting intangible assets ($150.60 Million) from net assets ($752.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See RNAC total equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cartesian Therapeutics Inc. Tangible Net Worth Ratio (2016–2022)
This chart shows how Cartesian Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 5 annual periods from 2016 to 2022. As of September 2024, the ratio stands at -19926.6%, reflecting net assets of $752.00K with intangible assets of $150.60 Million USD. Also explore Cartesian Therapeutics Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Cartesian Therapeutics Inc. (2016–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Cartesian Therapeutics Inc. from 2016 to 2022, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Cartesian Therapeutics Inc. (RNAC) total market value.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $93.83 Million | $0.00 | $165.89 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $22.52 Million | $0.00 | $159.88 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $8.40 Million | $0.00 | $99.57 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $51.81 Million | $0.00 | $101.10 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $54.96 Million | $0.00 | $89.30 Million | — |